Delivery of functional DNA and messenger RNA to mammalian phagocytic cells by recombinant yeast

Gene Therapy

Volumn 19, Issue 3, 2012, Pages 237-245

  Walch, B ^a   Breinig, T ^a,b   Schmitt, M J ^a   Breinig, F ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

antigen presenting cell; DNA delivery; RNA delivery; T cell activation; yeast

Indexed keywords

CD69 ANTIGEN; CYTOMEGALOVIRUS ANTIGEN PP65; DNA; GAMMA INTERFERON; ISOCITRATE LYASE; LISTERIOLYSIN; LIVE VACCINE; MESSENGER RNA;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOSOL; DENDRITIC CELL; GENE TARGETING; HUMAN; HUMAN CELL; MACROPHAGE; MAMMAL CELL; MONOCYTE; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; RNA TRANSLATION; SACCHAROMYCES CEREVISIAE;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; CELL LINE; DENDRITIC CELLS; DNA; GENE TRANSFER TECHNIQUES; HUMANS; MACROPHAGES; MICE; PHAGOCYTES; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE; TRANSGENES;

BACTERIA (MICROORGANISMS); MAMMALIA; MURINAE; SACCHAROMYCES CEREVISIAE;

EID: 84858005306     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2011.121     Document Type: Article

References (50)

1. Rice J, Ottensmeier CH, Stevenson FK. DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer 2008; 8: 108-120. (Pubitemid 351161331)
2. Pilgrim S, Stritzker J, Schoen C, Kolb-Maurer A, Geginat G, Loessner MJ et al. Bactofection of mammalian cells by Listeria monocytogenes: improvement and mechanism of DNA delivery. Gene Therapy 2003; 10: 2036-2045. (Pubitemid 37407100)
3. Pascolo S. Vaccination with messenger RNA (mRNA). Handb Exp Pharmacol 2008: 221-235.
4. Weiss S, Krusch S. Bacteria-mediated transfer of eukaryotic expression plasmids into mammalian host cells. Biol Chem 2001; 382: 533-541. (Pubitemid 32472166)
5. Schoen C, Kolb-Maurer A, Geginat G, Loffler D, Bergmann B, Stritzker J et al. Bacterial delivery of functional messenger RNA to mammalian cells. Cell Microbiol 2005; 7: 709-724. (Pubitemid 40585012)
6. Loeffler DI, Schoen CU, Goebel W, Pilgrim S. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes. Infect Immun 2006; 74: 3946-3957. (Pubitemid 43993327)
7. Darji A, zur Lage S, Garbe AI, Chakraborty T, Weiss S. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier. FEMS Immunol Med Microbiol 2000; 27: 341-349. (Pubitemid 30155829)
8. Lewis GK. Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet? Expert Rev Vaccines 2007; 6: 431-440. (Pubitemid 46911605)
9. Howland SW, Wittrup KD. Antigen release kinetics in the phagosome are critical to cross-presentation efficiency. J Immunol 2008; 180: 1576-1583.
10. Wadle A, Held G, Neumann F, Kleber S, Wuellner B, Asemissen AM et al. Cross-presentation of HLA class I epitopes from influenza matrix protein produced in Saccharomyces cerevisiae. Vaccine 2006; 24: 6272-6281. (Pubitemid 44262415)
11. Stubbs AC, Martin KS, Coeshott C, Skaates SV, Kuritzkes DR, Bellgrau D et al. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat Med 2001; 7: 625-629. (Pubitemid 32448332)
12. Stubbs AC, Wilson CC. Recombinant yeast as a vaccine vector for the induction of cytotoxic T-lymphocyte responses. Curr Opin Mol Ther 2002; 4: 35-40. (Pubitemid 34649791)
13. Haller AA, Lauer GM, King TH, Kemmler C, Fiolkoski V, Lu Y et al. Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and core proteins. Vaccine 2007; 25: 1452-1463. (Pubitemid 46074294)
14. Lu Y, Bellgrau D, Dwyer-Nield LD, Malkinson AM, Duke RC, Rodell TC et al. Mutation-selective tumor remission with Ras-targeted, whole yeast-based immunotherapy. Cancer Res 2004; 64: 5084-5088. (Pubitemid 39006523)
15. Bernstein MB, Chakraborty M, Wansley EK, Guo Z, Franzusoff A, Mostbock S et al. Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells. Vaccine 2008; 26: 509-521.
16. Wansley EK, Chakraborty M, Hance KW, Bernstein MB, Boehm AL, Guo Z et al. Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses. Clin Cancer Res 2008; 14: 4316-4325.
17. Remondo C, Cereda V, Mostbock S, Sabzevari H, Franzusoff A, Schlom J et al. Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen. Vaccine 2009; 27: 987-994.
18. Ardiani A, Higgins JP, Hodge JW. Vaccines based on whole recombinant Saccharomyces cerevisiae cells. FEMS Yeast Res 2010; 10: 1060-1069.
19. Tanaka A, Jensen JD, Prado R, Riemann H, Shellman YG, Norris DA et al. Whole recombinant yeast vaccine induces antitumor immunity and improves survival in a genetically engineered mouse model of melanoma. Gene Therapy 2011; 18: 827-834.
20. Heintel T, Breinig F, Schmitt MJ, Meyerhans A. Extensive MHC class I-restricted CD8 T lymphocyte responses against various yeast genera in humans. FEMS Immunol Med Microbiol 2003; 39: 279-286. (Pubitemid 37456837)
21. Beier R, Gebert A. Kinetics of particle uptake in the domes of Peyer's patches. Am J Physiol 1998; 275: G130-G137.
22. Lorenz MC, Bender JA, Fink GR. Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot Cell 2004; 3: 1076-1087. (Pubitemid 39385215)
23. Lorenz MC, Fink GR. The glyoxylate cycle is required for fungal virulence. Nature 2001; 412: 83-86. (Pubitemid 32851514)
24. Evstafieva AG, Beletsky AV, Borovjagin AV, Bogdanov AA. Internal ribosome entry site of encephalomyocarditis virus RNA is unable to direct translation in Saccharomyces cerevisiae. FEBS Lett 1993; 335: 273-276. (Pubitemid 23350422)
25. Jackson RJ, Standart N. Do the poly(A) tail and 3′ untranslated region control mRNA translation? Cell 1990; 62: 15-24.
26. Holtkamp S, Kreiter S, Selmi A, Simon P, Koslowski M, Huber C et al. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood 2006; 108: 4009-4017. (Pubitemid 44913269)
27. Dietrich G, Bubert A, Gentschev I, Sokolovic Z, Simm A, Catic A et al. Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Nat Biotechnol 1998; 16: 181-185. (Pubitemid 28078508)
28. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415-419. (Pubitemid 37296260)
29. Lauterbach H, Gruber A, Ried C, Cheminay C, Brocker T. Insufficient APC capacities of dendritic cells in gene gun-mediated DNA vaccination. J Immunol 2006; 176: 4600-4607.
30. Van Tendeloo VF, Ponsaerts P, Berneman ZN. mRNA-based gene transfer as a tool for gene and cell therapy. Curr Opin Mol Ther 2007; 9: 423-431. (Pubitemid 47574618)
31. Abdulhaqq SA, Weiner DB. DNA vaccines: developing new strategies to enhance immune responses. Immunol Res 2008; 42: 219-232.
32. Breinig F, Heintel T, Schumacher A, Meyerhans A, Schmitt MJ. Specific activation of CMV-primed human T lymphocytes by cytomegalovirus pp65 expressed in fission yeast. FEMS Immunol Med Microbiol 2003; 38: 231-239. (Pubitemid 37289747)
33. Walch B, Breinig T, Geginat G, Schmitt MJ, Breinig F. Yeast-based protein delivery to mammalian phagocytic cells is increased by coexpression of bacterial listeriolysin. Microbes Infect 2011; e-pub ahead of print 27 May 2011; doi:10.1016/ j.micinf.2011.05.006.
34. Kern F, Bunde T, Faulhaber N, Kiecker F, Khatamzas E, Rudawski IM et al. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J Infect Dis 2002; 185: 1709-1716. (Pubitemid 34615463)
35. Wills MR, Carmichael AJ, Mynard K, Jin X, Weekes MP, Plachter B et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 1996; 70: 7569-7579. (Pubitemid 26340108)
36. Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002; 169: 1984-1992. (Pubitemid 34857662)
37. Forman SJ, Zaia JA, Clark BR, Wright CL, Mill BJ, Pottahil R et al. A 64000 dalton matrix protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigen. J Immunol 1985; 134: 3391-3395. (Pubitemid 15246483)
38. Guzman CA, Domann E, Rohde M, Bruder D, Darji A, Weiss S et al. Apoptosis of mouse dendritic cells is triggered by listeriolysin, the major virulence determinant of Listeria monocytogenes. Mol Microbiol 1996; 20: 119-126. (Pubitemid 26126050)
39. Carrero JA, Calderon B, Unanue ER. Listeriolysin O from Listeria monocytogenes is a lymphocyte apoptogenic molecule. J Immunol 2004; 172: 4866-4874. (Pubitemid 38456410)
40. Carrero JA, Vivanco-Cid H, Unanue ER. Granzymes drive a rapid listeriolysin O-induced T cell apoptosis. J Immunol 2008; 181: 1365-1374.
41. Ackerman AL, Giodini A, Cresswell P. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 2006; 25: 607-617. (Pubitemid 44529035)
42. Ackerman AL, Kyritsis C, Tampe R, Cresswell P. Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. Nat Immunol 2005; 6: 107-113. (Pubitemid 40136702)
43. Franzusoff A, Duke RC, King TH, Lu Y, Rodell TC. Yeasts encoding tumour antigens in cancer immunotherapy. Expert Opin Biol Ther 2005; 5: 565-575. (Pubitemid 40593339)
44. Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 1989; 77: 61-68. (Pubitemid 19125654)
45. Breinig F, Schmitt MJ. Spacer-elongated cell wall fusion proteins improve cell surface expression in the yeast Saccharomyces cerevisiae. Appl Microbiol Biotechnol 2002; 58: 637-644. (Pubitemid 34299228)
46. Breinig F, Schleinkofer K, Schmitt MJ. Yeast Kre1p is GPI-anchored and involved in both cell wall assembly and architecture. Microbiology 2004; 150: 3209-3218. (Pubitemid 39406192)
47. Heiligenstein S, Eisfeld K, Sendzik T, Jimenez-Becker N, Breinig F, Schmitt MJ. Retrotranslocation of a viral A/B toxin from the yeast endoplasmic reticulum is independent of ubiquitination and ERAD. EMBO J 2006; 25: 4717-4727. (Pubitemid 44607018)
48. Ito H, Fukuda Y, Murata K, Kimura A. Transformation of intact yeast cells treated with alkali cations. J Bacteriol 1983; 153: 163-168. (Pubitemid 13119852)
49. Schutz A, Scheller N, Breinig T, Meyerhans A. The Autographa californica nuclear polyhedrosis virus AcNPV induces functional maturation of human monocyte-derived dendritic cells. Vaccine 2006; 24: 7190-7196. (Pubitemid 46127448)
50. Scheller N, Furtwangler R, Sester U, Maier R, Breinig T, Meyerhans A. Human cytomegalovirus protein pp65: an efficient protein carrier system into human dendritic cells. Gene Therapy 2008; 15: 318-325. (Pubitemid 351223468)